What is the long-term trend for aTyr Pharma's available for sale securities debt securities current?

Over 5 years (2020 to 2025), aTyr Pharma's available for sale securities debt securities current has grown at a 35.8% compound annual growth rate (CAGR), from $14.74M to $67.94M.

aTyr Pharma ATYR Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Bristol-Myers SquibbBMY

$912M+0.6%

CytomX TherapeuticsCTMX

——

Oric Pharmaceuticals, Inc.ORIC

——

Stoke Therapeutics, Inc.STOK

——

Viridian Therapeutics, Inc.VRDN

——

Spyre Therapeutics, Inc.SYRE

——

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's available for sale securities debt securities current?: aTyr Pharma (ATYR) reported available for sale securities debt securities current of $56.51M in Q1 2026.
How has aTyr Pharma's available for sale securities debt securities current changed year-over-year?: aTyr Pharma's available for sale securities debt securities current decreased by 14.4% year-over-year, from $65.99M to $56.51M.
What is the long-term trend for aTyr Pharma's available for sale securities debt securities current?: Over 5 years (2020 to 2025), aTyr Pharma's available for sale securities debt securities current has grown at a 35.8% compound annual growth rate (CAGR), from $14.74M to $67.94M.